EAU 2018

REVIEW UroToday

Viewing 1-20 of 223 articles

EAU 2018: Precision Medicine in Renal Cell Cancer, Can We Select The Treatment?

EAU 2018: Molecular Heterogeneity Between Primary Tumors and Metastases in Renal Cell Cancer

EAU 2018: Molecular and Histopathological Heterogeneity in Muscle-Invasive Bladder Cancer

EAU 2018: The Critically Ill Patient with Locally Advanced Bladder Cancer – Ureterocutaneostomy? YES

EAU 2018: The Critically Ill Patient with Locally Advanced Bladder Cancer – Ureterocutaneostomy? NO

EAU 2018: Optimizing Anesthesia in the Frail Patient with Bladder Cancer: What the Urologist Needs to Know

EAU 2018: Results from the TRACERx Renal Study: Deterministic Routes to Tumor Progression in Clear Cell Renal Cell Carcinoma

EAU 2018: Latest in Medical Treatment - Renal Cell Cancer

EAU 2018: Analysis shows influential US prostate study not representative of real-world patients

EAU 2018: Hormone-Naive Prostate Cancer

EAU 2018: Highlights from ASCO-GU 2018

EAU 2018: Castration Resistant Prostate Cancer

EAU 2018: Urothelial Cancer – A Year in Highlights

EAU 2018: Clinicopathologic Factors Linked to Intravesical Recurrence after Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma

EAU 2018: Can We Rely on Urinary Markers?

EAU 2018: Instillations in The Upper Tract: Which Technique?

EAU 2018: Challenges in Prevention of Bladder Recurrence

EAU 2018: Now or Never - Realizing the Promise of Precision Oncology for Urothelial Carcinoma

EAU 2018: Does New Molecular Subtyping in Urothelial Cancer Add to Tumor, Nodes and Metastasis

EAU 2018: Urogenital Tuberculosis: The Cause Of Ineffective Antibacterial Therapy For Urinary Tract Infections

1
2
3
4
5
6
7
8
9
10